| ■ Doctors Reminded About Safe Use of HIV Drug in Children | 2007.08.18 |
| Doctors need to be careful when using the anti-HIV drug Kaletra in children, says an Abbott Laboratories letter posted on the U.S. Food and Drug Administration's Web site. The drug maker wrote the letter after the accidental overdose death of an infant born with HIV, who died nine days after receiving a 6.5 millimeter dose of Kaletra, the Associated Press reported. In the letter, Abbott reminds doctors that children should receive less than a 5 millimeter dose of Kaletra oral solution. "Special attention must be paid to accurate calculation of the dose, transcription of the medication order, dispensing information and dosing instructions to minimize the risk of medication," the letter states. |